Text Module

Share

Program Content

Activities

  • Targeting DLL3 in ES-SCLC
    Future Applications in ES-SCLC: Targeting DLL3 and Emerging Evidence for T-Cell Engagers
    Text Module
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 07, 2024

    Expires: May 06, 2025

Faculty

cover img faculity

Carl M. Gay, MD, PhD

Assistant Professor
Thoracic/Head & Neck Medical Oncology
The University of Texas MD Anderson Cancer Center
Houston, Texas

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

This activity is supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

Boehringer Ingelheim Pharmaceuticals, Inc.